AMGN · 10-Q · 2026Q2 · Full report

Operating Income and Margins

AMGEN INC · 2026-08-05 · Importance 69 · Surprise 64 · No source text

Second-quarter 2026 operating income increased 32.3% year over year to $3.514 billion from $2.656 billion, lifting operating margin to approximately 35.0% from 28.9%. Six-month operating income increased 61.2% to $6.180 billion from $3.834 billion, and operating margin increased to approximately 33.1% from 22.1%. Six-month cost of sales declined 7.1% to $5.555 billion from $5.979 billion, primarily reflecting lower finite-lived intangible-asset amortization of $1.8 billion versus $2.3 billion in the prior-year period. Second-quarter research and development expense increased 7.1% to $1.868 billion, partially offsetting the benefit from lower cost of sales.

Key facts

• Operating income for the six months ended June 30, 2026: $6,180 million; for the six months ended June 30, 2025: $3,834 million. source
• Net income for the three months ended June 30, 2026: $2,375 million; for the three months ended June 30, 2025: $1,432 million. source
• Operating income for the three months ended June 30, 2026: $3,514 million; for the three months ended June 30, 2025: $2,656 million. source
• Diluted EPS for the three months ended June 30, 2026: $4.37; for the three months ended June 30, 2025: $2.65. source
• Three months ended June 30, 2026 Operating income: $3,514 million source
• Six months ended June 30, 2026 Operating income: $6,180 million source
• Three months ended June 30, 2026 Net income: $2,375 million source
• Six months ended June 30, 2026 Net income: $4,194 million source

Impact estimates